Lunger John has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 1612032 shares of Adaptimmune Therapeutics PLC ($ADAPY) on February 20, 2025.
Activity breakdown: 0 open-market purchases and 9 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | A | Option to purchase Ordinary Shares | 1612032 | $0.00 | 1,612,032.0000 | 1,513,810,852 | 9999.99% | 0.11% |
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | A | Option to purchase Ordinary Shares | 1074696 | $0.00 | 1,074,696.0000 | 1,513,810,852 | 9999.99% | 0.07% |
| Jan. 17, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 5584 | $0.58 | 7,510.0000 | 1,513,810,852 | 42.65% | 0.00% |
| Jan. 13, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 4268 | $0.59 | 5,845.0000 | 1,513,810,852 | 42.20% | 0.00% |
| Jan. 13, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 5471 | $0.59 | 7,623.0000 | 1,513,810,852 | 41.78% | 0.00% |
| Jan. 15, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 9803 | $0.57 | 13,756.0000 | 1,513,810,852 | 41.61% | 0.00% |
| Jan. 16, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 4681 | $0.79 | 7,023.0000 | 1,206,440,978 | 39.99% | 0.00% |
| Jan. 17, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 5309 | $0.67 | 7,785.0000 | 1,206,440,978 | 40.55% | 0.00% |
| Jan. 17, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 12805 | $0.67 | 19,015.0000 | 1,206,440,978 | 40.24% | 0.00% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | A | Option to purchase Ordinary Shares | 2544432 | $0.00 | 2,544,432.0000 | 1,206,440,978 | 9999.99% | 0.21% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | A | Option to purchase Ordinary Shares | 565416 | $0.00 | 565,416.0000 | 1,206,440,978 | 9999.99% | 0.05% |
| Jan. 11, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 4009 | $0.84 | 6,104.0000 | 1,206,440,978 | 39.64% | 0.00% |
| Jan. 12, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Lunger John | Chief Patient Supply Officer | S | American Depositary Shares representing Ordinary Shares | 5220 | $0.85 | 7,874.0000 | 1,206,440,978 | 39.87% | 0.00% |